Charlesson LLC
Directory listingDirectory record status
These labels describe this UNITEMFG record. They do not guarantee current capabilities, certifications, capacity, quality, or fit for a specific job.
- Directory listing
- Listed
- Ownership
- Unclaimed
- Evidence reviewed
- Not recorded
- Last evidence review
- Not recorded
About
Charlesson LLC operates as a specialized pharmaceutical contract research organization based in Oklahoma City, Oklahoma, focusing on advanced ocular therapeutics development and preclinical research services. Located in the Presbyterian Health Foundation Research Park, the company provides comprehensive research and development solutions for global pharmaceutical companies seeking expertise in ophthalmic drug development. The company specializes in developing innovative treatments for critical eye diseases including age-related macular degeneration, diabetic retinopathy, and uveitis. Their core capabilities encompass preclinical ophthalmic research utilizing well-established and optimized testing models to evaluate novel therapeutic agents and treatment modalities. With over two decades of scientific expertise, Charlesson delivers tailored research solutions designed to accelerate pharmaceutical development timelines. A key differentiator is their proprietary MiDROPS drug delivery system, which employs advanced microemulsion technology to enhance ocular penetration of lipophilic compounds. This innovative approach addresses critical challenges in ophthalmic drug delivery, backed by an extensive patent portfolio protecting various formulation technologies. Charlesson generates significant revenue through outsourced research and development services, serving leading pharmaceutical manufacturers worldwide. Their specialized focus on ocular therapeutics, combined with proven preclinical research methodologies and innovative delivery systems, positions them as a valuable partner for companies developing next-generation eye treatments. The company maintains operations that support both proprietary drug development programs and contract research services for external clients.